發送短信 : Switching to Fixed-Dose Bictegravir, Emtricitabine, and Tenofovir Alafenamide (B/F/TAF) in Virologically Suppressed HIV-1 Infected Women: A Randomized, Open-Label, Multicenter, Active-Controlled, Phase 3, Noninferiority Trial

   _____   _    _                ___     __   _   
  / ___// | || | ||   ____      / _ \\  | || | || 
  \___ \\ | || | ||  |    \\   | / \ || | '--' || 
  /    // | \\_/ ||  | [] ||   | \_/ || | .--. || 
 /____//   \____//   |  __//    \___//  |_|| |_|| 
`-----`     `---`    |_|`-`     `---`   `-`  `-`  
                     `-`